Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men

Journal of Hypertension

Volumn 18, Issue 1, 2000, Pages 35-43

  Vanhees, Luc ^a,b,d   Defoor, Johan G M ^b   Schepers, Dirk ^b   Lijnen, Paul ^a   Peeters, Brigitte Y M ^c   Lacante, Paul H L ^c   Fagard, Robert H ^a  

^a Faculty of Medicine   (Belgium)

^b Department of Rehabilitation Sciences   (Belgium)

^c Medical Department   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Atenolol; Bisoprolol; CO2 rebreathing; Endurance exercise; adrenoceptor blockade

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; FATTY ACID; RENIN;

ADULT; ARTICLE; BICYCLE ERGOMETER; CARBON DIOXIDE BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FATTY ACID BLOOD LEVEL; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE STRENGTH; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBREATHING; SYSTOLIC BLOOD PRESSURE; VENOUS BLOOD;

EID: 0033965396     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018010-00006     Document Type: Article

References (35)

1. 1 Fagard R, Amery A. Physical exercise in hypertension. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysrology, diagnosis and management. New York: Raven Press; 1995. pp. 2669-2681.
2. 2 Tesch A. Exercise performance and β-blockade. Sports Med 1985; 2:389-412.
3. 3 Van Baak MA. β-adrenoceptor blockade and exercise. An update. Sports Med 1988; 4:209-225.
4. 2-blockade on exercise endurance and muscle metabolism in humans. J Appl Physiol 1989; 66:548-554.
5. 5 Laustiola K, Uusitalo A, Koivula T, Sovijarvi A, Seppala E, Nikkari T, et al. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men. Eur J Clin Pharmacol 1983; 25:293-297.
6. 6 Van Baak MA, Mooij JM, Wijnen JA. Effect of increased plasma non-esterified fatty acid concentrations on endurance performance during beta-adrenoceptor blockade. Int J Sports Med 1993; 14:2-8.
7. 7 Verstappen FT, Van Baak MA. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Eur J Appl Physiol 1987; 56:712-718.
8. 2-rebreathing. Med Sci Sports Exerc, in press.
9. 9 Kendall MJ, Akhlaghi S, Haffner CA. Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline. J Clin Pharm Ther 1991; 16:25-29.
10. 10 Schliep HJ, Hartling J. Beta 1 -selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. J Cardiovasc Pharmacol 1984; 6:1156-1160.
11. 11 Chang PC, van Veen S, Van Der Krogt JA, Vermeij P, Van Brummelen P. Beta 1 -adrenoceptor selectivity of single doses of bisoprolol and atenolol. J Cardiovasc Pharmacol 1988; 12:317-322.
12. 12 Van Bortel LM, Van Baak MA. Exercise tolerance with nebivolol and atenolol. Cardiovasc Drugs Ther 1992; 6:239-247.
13. 13 Vanhees L, Fagard R, Amery A. Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men. Eur J Appl Physiol 1988; 58:87-91.
14. 14 Vanhees L, Fagard R, Lijnen P, Amery A. Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen. J Hypertens 1991; 9:1063-1068.
15. 15 Bolli P, Muller FB, Linder L, Ji BH, Buhler FR. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol. J Cardiovasc Pharmacol 1986; 8 (suppl 11):S61-S64.
16. 16 Colantonio D, Casale R, Desiati P, Giadomenico G, Bucci V, Pasqualetti P. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension. J Clin Pharmacol 1991; 31:238-242.
17. 2-antagonism. Med Sci Sports Exerc 1986; 18:186-191.
18. 18 Gluck Z, Reubi FC. Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent. Eur J Clin Pharmacol 1986; 31:107-111.
19. 19 Tham TC, Silke B, Taylor SH. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension. J Hum Hypertens 1990; 4 (suppl 2):77-83.
20. 20 Nieminnen MS, Rapola J, Pellinen TJ, Toivonen L. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers. Ann Clin Res 1988; 20:431-435.
21. 2-adrenoceptor blockade on left ventricular function in humans. J Cardiovasc Pharmacol 1986; 8:1086-1091.
22. 22 Vanhees L, Fagard R, Amery A. Effect of verapamil on systemic and brachial artery hemodynamics in normal humans: comparison with effect of atenolol. J Cardiovasc Pharmacol 1989; 14:642-647.
23. 1 -adrenoceptor blockade in hypertensive man. Clin Physiol 1985; 5:231-242.
24. 24 Leeman M, van de Borne P, Collart F, Vandenhoven G, Peeters L, Melot C, et al. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure. J Cardiovasc Pharmacol 1993; 22:785-791.
25. 25 Wijnen JA, Van Baak MA, de Haan C, Boudier HA, Tan FS, Van Bortel LM. Beta-blockade and lipolysis during endurance exercise. Eur J Clin Pharmacol 1993; 45:101-105.
26. 26 Head A, Maxwell S, Kendall MJ. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo. Br J Sports Med 1997; 31:120-125.
27. 27 Cosenzi A, Sacerdote A, Bocin E, Molino R, Mangiarotti M, Bellini G. Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise. J Cardiovasc Pharmacol 1995; 25:142-146.
28. 28 Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J. Substrate turn-over during prolonged exercise in man. J Clin Invest 1974; 53:1080-1090.
29. 29 Schrauwen P, Van Baak MA. The effect of beta-adrenergic blockade on non-esterified fatty acid uptake of exercising skeletal muscle during arm cranking. Int J Sports Med 1995; 16:439-444.
30. 30 Jesek JK, Martin NB, Broeder CE, Thomas EL, Wambsgans KC, Hofman Z, et al. Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol. Am J Cardiol 1990; 66:1336-1341.
31. 31 Van Baak MA, Böhm ROB, Arends BG, van Hooff MEJ, Rahn KH. Long-term antihypertensive therapy with beta blockers: submaximal exercise capacity and metabolic effects during exercise. Int J Sports Med 1987; 8:342-374.
32. 32 Van Baak MA, de Haan A, Saris WH, van Kordelaar E, Kuipers H, van Der Vusse GJ. β-adrenoceptor blockade and skeletal muscle energy metabolism during endurance exercise. J Appl Physiol 1995; 78:307-313.
33. 33 Sjøgaard G, Adams RP, Saltin B. Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol 1985; 248:R190-R196.
34. 34 Lindinger MI. Potassium regulation during exercise and recovery in humans: impliciations for skeletal and cardiac muscle. J Mol Cell Cardiol 1995; 27:1011-1022.
35. 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K transport in rat soleus muscle. Br J Pharmacol 1980; 68:749-755.